Safety and Protective Efficacy of Genetically Attenuated Pf∆b9∆Slarp (PfSPZ-GA1) Malaria Parasites in Healthy Dutch Volunteers
Phase of Trial: Phase I
Latest Information Update: 07 Mar 2019
Price : $35 *
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary)
- Indications Malaria
- Focus Adverse reactions; First in man
- Sponsors Sanaria
- 04 Mar 2019 Status changed from recruiting to completed.
- 08 Oct 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Oct 2018.
- 26 May 2017 New trial record